T1	MergerAcquisition 4 34	turns hostile with $ 2.6bn bid
A1	Confidence T1 SomewhatCertain
A2	MergerAcquisition_Other T1
T2	Company 39 42	HGS
T3	Company 0 3	GSK
T4	MergerAcquisition 60 95	has formally turned its $ 2.6bn bid
A3	Confidence T4 SomewhatCertain
A4	MergerAcquisition_Other T4
T5	MergerAcquisition 122 129	hostile
A5	Confidence T5 SomewhatCertain
A6	MergerAcquisition_Other T5
*	in_span_with T5 T4
T6	Company 100 121	Human Genome Sciences
T7	Company 44 59	GlaxoSmithKline
R1	is_about_acquirer Arg1:T4 Arg2:T7	
R2	is_about_target Arg1:T4 Arg2:T6	
T8	MergerAcquisition 926 947	a hostile $ 6.8bn bid
A7	Confidence T8 Certain
A8	MergerAcquisition_NoMergerAcquisition T8
T9	MergerAcquisition 999 1027	which it withdrew last month
A9	Confidence T9 Certain
A10	MergerAcquisition_NoMergerAcquisition T9
*	in_span_with T8 T9
T10	Company 951 956	Roche
T11	Company 961 969	Illumina
R3	is_about_acquirer Arg1:T8 Arg2:T10	
R4	is_about_target Arg1:T8 Arg2:T11	
R5	is_about_acquirer Arg1:T1 Arg2:T3	
R6	is_about_target Arg1:T1 Arg2:T2	
